ECSP003351A - Composiciones farmaceuticas - Google Patents

Composiciones farmaceuticas

Info

Publication number
ECSP003351A
ECSP003351A ECSP003351A ECSP003351A EC SP003351 A ECSP003351 A EC SP003351A EC SP003351 A ECSP003351 A EC SP003351A EC SP003351 A ECSP003351 A EC SP003351A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical compositions
bioavailability
benzoyl staurosporine
levels
compositions
Prior art date
Application number
Other languages
English (en)
Inventor
Graham Paul Matthews
Barbara Haberlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003351 priority Critical patent/ECSP003351A/es
Publication of ECSP003351A publication Critical patent/ECSP003351A/es

Links

Abstract

Se describen composiciones de N-benzoil-estaurosporina espontáneamente desipersables para la administarción oral, que tienen alqtos niveles de biodisponibilidad, y una variedad reducida de lso niveles de biodisponibilidad de N-benzoil estaturosporina, asi como su preparación y su uso en tratamiento médico.
ECSP003351 2000-02-15 2000-02-15 Composiciones farmaceuticas ECSP003351A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003351 ECSP003351A (es) 2000-02-15 2000-02-15 Composiciones farmaceuticas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003351 ECSP003351A (es) 2000-02-15 2000-02-15 Composiciones farmaceuticas

Publications (1)

Publication Number Publication Date
ECSP003351A true ECSP003351A (es) 2000-05-08

Family

ID=42040982

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003351 ECSP003351A (es) 2000-02-15 2000-02-15 Composiciones farmaceuticas

Country Status (1)

Country Link
EC (1) ECSP003351A (es)

Similar Documents

Publication Publication Date Title
ECSP083351A (es) Composiciones farmacéuticas
CY1105262T1 (el) Φαρμακευτικες συνθεσεις παρατεταμενης απελευθερωσης για την παρεντepικη χορηγηση βιολογικως δραστικων υδροφιλων ενωσεων
WO2004112711A3 (en) Oral extended-release composition
EE05081B1 (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, 3-aminoasetidiini derivaadid ja nende valmistamise meetodid
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
EE05383B1 (et) Polarlkarboksamiidhendid,ÁnendeÁvalmistamineÁjaÁkasutamineÁlipiiditasetÁalandavateÁtoimeainetenaÁningÁneidÁsisaldavÁfarmatseutilineÁkompositsioon
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
EP1483277A4 (en) CONJUGATES OF BIOLOGICALLY ACTIVE COMPOUNDS, METHODS OF PREPARATION AND USE, AND FORMULATION AND PHARMACEUTICAL APPLICATIONS
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
PT1401501E (pt) Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
AU2003215245A8 (en) Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
AR034517A1 (es) Formulacion farmaceutica
PT1383752E (pt) 3-piperidinopropiofenonas deuteradas assim como farmacos contendo estes compostos
UA86776C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение
TNSN05222A1 (en) Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluoroanilino) phenylacetic acid
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
ATE398109T1 (de) 4-pyrimidinamine derivate, pharmazeutische zusammenstellungen und verwandte methoden
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
SE0001916D0 (sv) Novel formulation
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
ECSP003351A (es) Composiciones farmaceuticas
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение